首页> 外国专利> METHOD FOR PREDICTING AND MODELING ANTI-PSYCHOTIC ACTIVITY USING VIRTUAL SCREENING MODEL

METHOD FOR PREDICTING AND MODELING ANTI-PSYCHOTIC ACTIVITY USING VIRTUAL SCREENING MODEL

机译:虚拟筛选模型预测和模拟抗抑郁活性的方法

摘要

The present invention relates to the development of a virtual screening model for predicting antipsychotic activity using quantitative structure activity relationship (QSAR), molecular docking, oral bioavailability, ADME and Toxicity studies. The present invention also relates to the development of QSAR model using forward stepwise method of multiple linear regression with leave-one-out validation approach. QSAR model showed activity-descriptors relationship correlating measure (r2) 0.87 (87%) and predictive accuracy of 81% (rCV2=0.81). The present invention specifically showed strong binding affinity of the untested (unknown) novel compounds against anti-psychotic targets viz., Dopamine D2 and Serotonin (5HT2A) receptors through molecular docking approach. Theoretical results were in accord with the in vitro and in vivo experimental data. The present invention further showed compliance of Lipinski's rule of five for oral bioavailability and toxicity risk assessment for all the active Yohimbine derivatives. Therefore, use of developed virtual screening model will definitely facilitate the screening of more effective antipsychotic leads/drugs with improved antipsychotic activity and also reduced the drug discovery cost and duration.
机译:本发明涉及使用定量结构活性关系(QSAR),分子对接,口服生物利用度,ADME和毒性研究来预测抗精神病活性的虚拟筛选模型的开发。本发明还涉及使用具有留一法验证方法的多元线性回归的正向逐步方法开发QSAR模型。 QSAR模型的活动性-指标关系测度(r 2 )为0.87(87%),预测准确度为81%(rCV 2 = 0.81)。本发明特别显示了未测试的(未知的)新化合物通过分子对接方法对抗精神病性靶标,即多巴胺D2和5-羟色胺(5HT 2A )受体的强结合亲和力。理论结果与体外和体内实验数据一致。本发明还显示了针对所有活性育亨宾衍生物的口服生物利用度和毒性风险评估的利宾斯基五分法则的依从性。因此,使用开发的虚拟筛查模型肯定会促进具有改善的抗精神病活性的更有效的抗精神病药前导/药物的筛查,并且还会减少药物发现的成本和持续时间。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号